🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to share our journey using single-cell multi-omics to do deep immunophenotyping in patients with ICI myocarditis Circulation #CardioOnc Sean M Wu, MD PhD Single Cell Media ahajournals.org/doi/10.1161/CI…

Our primer on single-cell technologies and their role in cardio-oncology is out! Thank you to everyone that helped! doi.org/10.1016/j.jacc… Sarah Waliany, MD, MS Han Zhu Sean M Wu, MD PhD

Proud to announce that our lab site is live!! Check it out to see what we are about and for job opportunities in our lab & the Stanford Translational Cardio-Oncology Program! 👉🏻hanzhulab.com #cardiooncology #cardioimmunology Stanford CVI Stanford Medicine StanfordCVFellowship

We wrote a viewpoint article in Med by Cell Press highlighting groundbreaking Nature paper by Margaret Axelrod, MD, PhD Justin Balko Javid Moslehi. As a sci community, we chip away at the mechanism & targeted therapy for ICI myocarditis 🙌 Sean M Wu, MD PhD Vivian Huang sciencedirect.com/science/articl…

Honored to receive the Stanford CVI Manuscript Award for our pub in Circulation! What a great start for our new lab, and of course I'm eternally grateful for the dedicated mentorship of Sean M Wu, MD PhD @.PatriciaNguyen @.MarkDavis & the hard work of our team!! med.stanford.edu/cvi/translatio…

So proud of Vivian Huang in my lab who presented her work #AHA23 on T-cell/macrophage chemokine crosstalk in immunotherapy induced myocarditis and everyone in my lab who helped with this project and came to support. 🎉🎉what a pleasure to mentor this group of passionate people

So proud of my lab members at the Stanford University-Duke-Penn-Cornell symposium. 4 poster presentations from 4 members and a poster award won by our very own Vivian Huang for her work in T cell/macrophage crosstalk in ICI myocarditis. Congrats and great work, everyone! Stanford CVI

Proud to present this pre-print from my lab. Using single-cell multi-omics, 2 mice models, & pt samples, we found CXCR3 as a novel therapeutic target for ICI myocarditis critical for T-cell/macrophage crosstalk and perpetuation of cardiac inflammation biorxiv.org/content/10.110…

Margaret Axelrod, MD, PhD International Cardio-Oncology Society BalkoResearchLab Javid Moslehi And also was excited to present our lab’s work on cxcr3 blockade in ici myocarditis!! Proud of the folks in my lab Vivian Huang Yin Sun Noah Wagner who are working on this, as well as grateful to collaborators like Pilar Alcaide, PhD Abe Bayer who helped with this International Cardio-Oncology Society

Congratulations to Han Zhu and all authors! Happy to help contribute to this study, this is an awesome story further outlining important immunologic mechanisms and therapeutic approaches in ICI myocarditis ahajournals.org/doi/10.1161/CI…

Proud to share this new pub from my lab - “Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis” ahajournals.org/doi/10.1161/.... Congrats to first authors Vivian Huang and Yin Sun. Our first foray into targeted therapy for this devastating condition

Fighting cancer shouldn't cause heart damage. Research from Han Zhu and Stanford CVI researchers explores how to protect the heart during cancer treatment. Congrats on their #CardioOncology manuscript in Circulation Research. cvi.stanford.edu/mission/news_c… Sean M Wu, MD PhD Stanford Department of Medicine

#Immunotherapy saves lives, but it can harm the heart. A new study finds that blocking CXCR3 prevents deadly heart inflammation without reducing cancer-fighting power. More from #StanDOM's Han Zhu: stan.md/4kz6bsu